Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose...
Vous n'êtes pas connecté
Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose...
Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Teleflex (TFX) holds strong momentum in the Interventional arm and a favorable solvency. Yet, macroeconomic impacts and competitive environment...
Host Hotels (HST) is poised to benefit from the improvement in the group business and a gradual recovery in business transient, though macroeconomic...
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Welltower (WELL) is likely to benefit from the rise in senior citizens' healthcare spending, restructuring initiatives and capital-recycling efforts....
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
Roper (ROP) gains from solid momentum in its businesses, acquired assets and shareholder-friendly moves. However, rising operating costs and high...
Revvity's (RVTY) strong product portfolio raises optimism about the stock.